Skip to content
Screener

Roivant Sciences ROIV Q4 2025 Annual earnings

Reported May 20, 2026 · Before market open

Revenue$2.5MMiss by $894.5K
EPS-$0.36Miss by $0.10
Revenue estimate$3.4M
EPS estimate-$0.26

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$3.4M
EPS estimate-$0.41

Financials

Q4 2025

Income statement

See full
Revenue$2.5M-66.7%

Balance sheet

See full
Cash & equivalents$44.5M-52.6%
Total debt$107.4M+7.3%
Total equity$4.5B-3.4%
Total assets$5.7B+5.0%

Cash flow

See full
Operating cash flow-$163.8M+5.1%
CapEx$1.3M+55.5%
Free cash flow-$165.1M+4.8%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$19.82B+175%
Enterprise value$19.89B+176%
P/S2,400.1×+2,152×

Profitability

See full
FCF margin-9,183.5%-17,093pp

Returns & leverage

See full
Debt / equity0×0.0×
Current ratio18.4×-15.1×

Segments

By segment

See full
Reportable Segment$2.5M-66.7%

FAQ

When did Roivant Sciences report Q4 2025 earnings?
Roivant Sciences (ROIV) reported Q4 2025 earnings on May 20, 2026 before market open.
What were Roivant Sciences's Q4 2025 revenue and EPS?
Roivant Sciences reported revenue of $2.5M and eps of $-0.36 for Q4 2025.
Did Roivant Sciences beat estimates in Q4 2025?
Revenue missed the consensus estimate of $3.4M by $894.5K. EPS missed the consensus estimate of $-0.26 by $0.10.
Where can I find Roivant Sciences's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001635088-26-000060) and the 10-K periodic report (0001635088-26-000061) directly on SEC EDGAR. The filing index links above go to sec.gov.